22 mars: Crédit Agricole Brie Picardie : déclaration hebdo transactions su..
22 mars: ALCATEL-LUCENT : Alcatel-Lucent chargé de l'exploitation du systè..
22/03/2010 15:30:00

Next Generation Portable Water Quality Analyzer Introduced By SDIX

SDIX (Nasdaq: SDIX), a leading provider of biotechnology-based

products and services for a broad range of life science, biotech,

diagnostic, and food safety applications, today announced DeltaTox®

II, its next generation portable water quality field testing analyzer.

Designed for on-site screening at remote locations as well as for

laboratory-based water testing, the DeltaTox II analyzer replaces SDIX’s

existing DeltaTox devices, delivering test results within five minutes.

With both chemical and bio-contamination detection in one analyzer,

DeltaTox II provides rapid screening and characterization of potable

water and waste water as well as industrial and environmental water


SDIX water quality products like DeltaTox II are designed to reduce the

time and cost to test water while also providing reliable and accurate

results for informed decision making. Some customers have realized up to

50% total cost reduction versus competing alternatives.

DeltaTox II features include:

  • Fast results – rapid screening, within five minutes in the field

  • Detects both toxins and bio-contamination in one device – over 2,700

    harmful substances and chemical compounds have been documented to date

  • Improved ease-of-use – An intuitive, menu-driven user interface with

    over 50% larger backlit display screen provides more information than


  • Increased reliability – No electromechanical parts, 1 year full


  • Portable and durable – Small, rugged, lightweight (2.2 lbs) device

    made from high-strength engineering polymer, rechargeable lithium ion


SDIX water quality testing instruments are being used by over 70% of the

largest water utilities in the USA as well as wastewater treatment

facilities, industrial water treatment systems, and environmental and

eco-toxicological research organizations. These products are also

extensively used outside the U.S., in Asia, Europe and other regions

around the globe. DeltaTox II is expected to be available for sale the

second quarter of 2010. Pricing will be announced at that time.

Commenting, Michael Jones, SDIX Water Quality Market Manager, said,

“With the new DeltaTox II, customers will have more rapid, accurate,

reliable, and cost-effective results than ever, enabling them to feel

secure about their water consumption or use. Moreover, we feel it is

important to be introducing a next generation water toxicity analyzer at

a time when the global need for remote location testing is increasing

dramatically. DeltaTox II can also help us expand into new regions where

on-site testing is critical to ensure a safe water supply to the local


DeltaTox II is a member of SDIX’s family of water quality testing

products. For more information, call 800-544-8881, visit www.sdix.com

or www.sdix.com/deltatox.

About SDIX

SDIX is a biotechnology company, expert at creating advantage by

providing a broad range of quality, innovative and effective

immuno-solutions to the Pharmaceutical, Biotechnology, Diagnostics, and

Food Safety markets. For 20 years, SDIX has developed antibodies which

advance its customers’ immuno-based work – reducing time, labor, and

costs while increasing accuracy and reliability of results.

SDIX offers a full suite of integrated immuno-solution capabilities

including assay design, development, and production. In life science

markets, SDIX capabilities are being used to help discover the

mechanisms of disease, facilitate the development of new drugs, and

provide mechanisms for rapid diagnosis. For more information, visit www.sdix.com.

This news release may contain forward-looking statements reflecting

SDIX's current expectations. When used in this press release, words like

“anticipate”, “could”, “enable”, “estimate”, “intend”, “expect”,

“believe”, “potential”, “will”, “should”, “project”, “plan” and similar

expressions as they relate to SDIX are intended to identify said

forward-looking statements. Investors are cautioned that all

forward-looking statements involve risks and uncertainties, which may

cause actual results to differ from those anticipated by SDIX at this

time. Such risks and uncertainties include, without limitation, changes

in demand for products, the application of our technologies to various

uses, delays in product development, delays in market acceptance of new

products, retention of customers and employees, adequate supply of raw

materials, inability to obtain or delays in obtaining fourth party,

including AOAC, or required government approvals, the ability to meet

increased market demand, competition, protection of intellectual

property, non-infringement of intellectual property, seasonality, and

other factors more fully described in SDIX's public filings with the

U.S. Securities and Exchange Commission.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6220106&lang=en


Michael Jones

Market Manager, Water Quality



22 mars: Crédit Agricole Brie Picardie : déclaration hebdo transactions su..
22 mars: ALCATEL-LUCENT : Alcatel-Lucent chargé de l'exploitation du systè..

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
27 nov.
Min søster blev ramt af lungekræft da hun var 12 og erklæret dødsyg. Hun lå hospitalindlagt indtil h..
01 déc.
Når du er 16 år, så har du givet chattet og lært, at folk lyver ad helvede til på nettet.   Har man ..
29 nov.
Klart NEJ herfra. Giv de EU liderlige danske politikere et sviende nederlag. Selv om Merkel er ved a..
26 nov.
Janssen ligeledes meget begejstret for DuoBody, så i løbet af nogle år får vi forhåbentlig for alvor..
25 nov.
Nå, nu er der gået et år siden jeg skrev sidst. Jeg vil starte med at pointere, at jeg er inhabil i ..
29 nov.
Det har været megen diskussion hvilken aktie der vil stige mest de kommende år af de to. Jeg selv ha..
28 nov.
Til diverse "kamphaner"   Vær så venlig at henlægge Jeres evindelige plidder-pladder andetsteds ! Be..
27 nov.
Indtil videre er det eneste der er kommet ud af COP 1, 2, 3......osv kun et ufatteligt miljøsvineri ..
01 déc.
Jeg har regnet lidt på tidspunktet for godkendelse af Lyxumia i US, hvis FDA har accepteret ansøgnin..
28 nov.
Markedsværdien af Genmab er nu godt seks gange så meget som den tilsvarende værdi af Bavarian, og sp..

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
Cegid : prise de position sur le secteur stratégique du Management des Talents (People Management)
FAIVELEY TRANSPORT : Nombre d'actions et de droits de vote au 30 novembre 2015
Néovacs annonce son engagement dans l'immunothérapie du cancer, suivant les recommandations de son comité scientifique réuni à New-York le 17 novembre
FAURECIA : communiqué relatif à la cessation du contrat de liquidité avec Exane BNP Paribas et à la mise en oeuvre d'un contrat de liquidité avec Rotshchild & Cie Banque
NICOX : Nombre total de droits de vote au 30 novembre 2015

Buy and sell signals

  • Tendance
  • Moneymachine

Droit d'auteur Euroinvestor A/S 2015   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
mercredi 2 décembre 2015 07:54:18
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20151130.1 - EUROWEB2 - 2015-12-02 07:54:18 - 2015-12-02 07:54:18 - 4 - Website: OKAY